MorphoSys AG has appointed Lisa Rojkjaer, a medical doctor, as vice president and head of clinical development. Dr Rojkjaer joins the Germany-based antibody company from Novartis Pharma AG where she most recently held the position of head of medical affairs, haematology-Europe. Prior to her tenure at Novartis, she spent five years with Novo Nordisk in Copenhagen, Denmark and in Princeton, New Jersey, US as the director of global medical affairs biopharmaceuticals and later, director of clinical development haematology.
